Plasma ghrelin concentrations are positively associated with carotid artery atherosclerosis in males

Journal of Internal Medicine

Volumn 260, Issue 1, 2006, Pages 43-52

  Poykko S M ^a   Kellokoski, E ^a   Ukkola, O ^a   Kauma, H ^a   Paivansalo M ^a   Kesaniemi Y A ^a   Horkko S ^a  

^a UNIVERSITY OF OULU   (Finland)

Author keywords

Atherosclerosis; Hormones; Risk factors

Indexed keywords

C REACTIVE PROTEIN; GHRELIN; LOW DENSITY LIPOPROTEIN CHOLESTEROL;

ADULT; ANALYSIS OF COVARIANCE; ARTICLE; ATHEROSCLEROSIS; BODY MASS; CARDIOVASCULAR RISK; CAROTID ARTERY; CHOLESTEROL BLOOD LEVEL; COHORT ANALYSIS; CONTROLLED STUDY; CORRELATION ANALYSIS; ECHOGRAPHY; FEMALE; HORMONE BLOOD LEVEL; HUMAN; INTIMA; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; RADIOIMMUNOASSAY; RISK FACTOR; SMOKING; SYSTOLIC BLOOD PRESSURE;

ADULT; ATHEROSCLEROSIS; CAROTID STENOSIS; CHOLESTEROL; FEMALE; HUMANS; LINEAR MODELS; MALE; MIDDLE AGED; PEPTIDE HORMONES; RISK FACTORS; SEX FACTORS; SMOKING; TUNICA INTIMA; TUNICA MEDIA;

EID: 33745177636     PISSN: 09546820     EISSN: 13652796     Source Type: Journal    
DOI: 10.1111/j.1365-2796.2006.01661.x     Document Type: Article

References (43)

1. Kojima M Hosoda H Date Y Nakazato M Matsuo H Kangawa K. Ghrelin is a growth-hormone-releasing acylated peptide from stomach. Nature 1999 402: 656 60.
2. Gnanapavan S Kola B Bustin SA Morris DG McGee P Fairclough P et al. The tissue distribution of the mRNA of ghrelin and subtypes of its receptor, GHS-R, in humans. J Clin Endocrinol Metab 2002 87: 2988 91.
3. Katugampola SD Pallikaros Z Davenport AP. [125I-His(9)]-ghrelin, a novel radioligand for localizing GHS orphan receptors in human and rat tissue: up-regulation of receptors with athersclerosis. Br J Pharmacol 2001 134: 143 9.
4. Shintani M Ogawa Y Ebihara K Aizawa-Abe M Miyanaga F Takaya K et al. Ghrelin, an endogenous growth hormone secretagogue, is a novel orexigenic peptide that antagonizes leptin action through the activation of hypothalamic neuropeptide Y/Y1 receptor pathway. Diabetes 2001 50: 227 32.
5. Tschöp M Smiley DL Heiman ML. Ghrelin induces adiposity in rodents. Nature 2000 407: 908 13.
6. Nagaya N Kojima M Uematsu M Yamagishi M Hosoda H Oya H et al. Hemodynamic and hormonal effects of human ghrelin in healthy volunteers. Am J Physiol Regul Integr Comp Physiol 2001 280: R1483 7.
7. Enomoto M Nagaya N Uematsu M Okumura H Nakagawa E Ono F et al. Cardiovascular and hormonal effects of subcutaneous administration of ghrelin, a novel growth hormone-releasing peptide, in healthy humans. Clin Sci (Lond) 2003 105: 431 5.
8. Pöykkö SM Kellokoski E Hörkkö S Kauma H Kesäniemi YA Ukkola O. Low plasma ghrelin is associated with insulin resistance, hypertension, and the prevalence of type 2 diabetes. Diabetes 2003 52: 2546 53.
9. Chang L Ren Y Liu X Li WG Yang J Geng B et al. Protective effects of ghrelin on ischemia/reperfusion injury in the isolated rat heart. J Cardiovasc Pharmacol 2004 43: 165 70.
10. Wiley KE Davenport AP. Comparison of vasodilators in human internal mammary artery: ghrelin is a potent physiological antagonist of endothelin-1. Br J Pharmacol 2002 136: 1146 52.
11. Katugampola SD Kuc RE Maguire JJ Davenport AP. G-protein-coupled receptors in human atherosclerosis: comparison of vasoconstrictors (endothelin and thromboxane) with recently de-orphanized (urotensin-II, apelin and ghrelin) receptors. Clin Sci (Lond) 2002 103 ( Suppl. 48 171S 175S.
12. Pemberton CJ Tokola H Bagi Z Koller A Pöntinen J Ola A et al. Ghrelin induces vasoconstriction in the rat coronary vasculature without altering cardiac peptide secretion. Am J Physiol Heart Circ Physiol 2004 287: H1522 9.
13. Burke GL Evans GW Riley WA Sharrett AR Howard G Barnes RW et al. Arterial wall thickness is associated with prevalent cardiovascular disease in middle-aged adults. The Atherosclerosis Risk in Communities (ARIC) Study. Stroke 1995 26: 386 91.
14. Rantala AO Kauma H Lilja M Savolainen MJ Reunanen A Kesäniemi YA. Prevalence of the metabolic syndrome in drug-treated hypertensive patients and control subjects. J Intern Med 1999 245: 163 74.
15. Kiema TR Kauma H Rantala AO Lilja M Reunanen A Kesäniemi YA et al. Variation at the angiotensin-converting enzyme gene and angiotensinogen gene loci in relation to blood pressure. Hypertension 1996 28: 1070 5.
16. Gröschl M Wagner R Dotsch J Rascher W Rauh M. Preanalytical influences on the measurement of ghrelin. Clin Chem 2002 48: 1114 6.
17. Vogel RA Benitez RM. Noninvasive assessment of cardiovascular risk: from Framingham to the future. Rev Cardiovasc Med 2000 1: 34 42.
18. Fagerberg B Hulten LM Hulthe J. Plasma ghrelin, body fat, insulin resistance, and smoking in clinically healthy men: the atherosclerosis and insulin resistance study. Metabolism 2003 52: 1460 3.
19. Shimizu Y Nagaya N Teranishi Y Imazu M Yamamoto H Shokawa T et al. Ghrelin improves endothelial dysfunction through growth hormone-independent mechanisms in rats. Biochem Biophys Res Commun 2003 310: 830 5.
20. Nagaya N Moriya J Yasumura Y Uematsu M Ono F Shimizu W et al. Effects of ghrelin administration on left ventricular function, exercise capacity, and muscle wasting in patients with chronic heart failure. Circulation 2004 110: 3674 9.
21. Ross R. Atherosclerosis - an inflammatory disease. N Engl J Med 1999 340: 115 26.
22. Dimmeler S Haendeler J Zeiher AM. Regulation of endothelial cell apoptosis in atherothrombosis. Curr Opin Lipidol 2002 13: 531 6.
23. Li WG Gavrila D Liu X Wang L Gunnlaugsson S Stoll LL et al. Ghrelin inhibits proinflammatory responses and nuclear factor-kappaB activation in human endothelial cells. Circulation 2004 109: 2221 6.
24. Dembinski A Warzecha Z Ceranowicz P Tomaszewska R Stachura J Konturek SJ et al. Ghrelin attenuates the development of acute pancreatitis in rat. J Physiol Pharmacol 2003 54: 561 73.
25. Asakawa A Inui A Kaga T Yuzuriha H Nagata T Ueno N et al. Ghrelin is an appetite-stimulatory signal from stomach with structural resemblance to motilin. Gastroenterology 2001 120: 337 45.
26. Baldanzi G Filigheddu N Cutrupi S Catapano F Bonissoni S Fubini A et al. Ghrelin and des-acyl ghrelin inhibit cell death in cardiomyocytes and endothelial cells through ERK1/2 and PI 3-kinase/AKT. J Cell Biol 2002 159: 1029 39.
27. Purnell JQ Weigle DS Breen P Cummings DE. Ghrelin levels correlate with insulin levels, insulin resistance, and high-density lipoprotein cholesterol, but not with gender, menopausal status, or cortisol levels in humans. J Clin Endocrinol Metab 2003 88: 5747 52.
28. Beaumont NJ Skinner VO Tan TM Ramesh BS Byrne DJ MacColl GS et al. Ghrelin can bind to a species of high-density lipoprotein associated with paraoxonase. J Biol Chem 2003 278: 8877 80.
29. Okumura H Nagaya N Enomoto M Nakagawa E Oya H Kangawa K. Vasodilatory effect of ghrelin, an endogenous peptide from the stomach. J Cardiovasc Pharmacol 2002 39: 779 83.
30. Tentolouris N Makrilakis K Doulgerakis D Moyssakis I Kokkinos A Kyriaki D et al. Increased plasma ghrelin levels in chronic renal failure are not associated with hemodynamic parameters. Horm Metab Res 2005 37: 646 52.
31. Chan JL Bullen J Lee JH Yiannakouris N Mantzoros CS. Ghrelin levels are not regulated by recombinant leptin administration and/or three days of fasting in healthy subjects. J Clin Endocrinol Metab 2004 89: 335 43.
32. Barkan AL Dimaraki EV Jessup SK Symons KV Ermolenko M Jaffe CA. Ghrelin secretion in humans is sexually dimorphic, suppressed by somatostatin, and not affected by the ambient growth hormone levels. J Clin Endocrinol Metab 2003 88: 2180 4.
33. Gambineri A Pagotto U Tschöp M Vicennati V Manicardi E Carcello A et al. Anti-androgen treatment increases circulating ghrelin levels in obese women with polycystic ovary syndrome. J Endocrinol Invest 2003 26: 629 34.
34. Kellokoski E Pöykkö SM Karjalainen AH Ukkola O Heikkinen J Kesäniemi YA et al. Estrogen replacement therapy increases plasma ghrelin levels. J Clin Endocrinol Metab 2005 90: 2954 63.
35. Bodart V Febbraio M Demers A McNicoll N Pohankova P Perreault A et al. CD36 mediates the cardiovascular action of growth hormone-releasing peptides in the heart. Circ Res 2002 90: 844 9.
36. Stahlberg N Rico-Bautista E Fisher RM Wu X Cheung L Flores-Morales A et al. Female-predominant expression of fatty acid translocase/CD36 in rat and human liver. Endocrinology 2004 145: 1972 9.
37. Tschöp M Wawarta R Riepl RL Friedrich S Bidlingmaier M Landgraf R et al. Post-prandial decrease of circulating human ghrelin levels. J Endocrinol Invest 2001 24: RC19 21.
38. Cummings DE Purnell JQ Frayo RS Schmidova K Wisse BE Weigle DS. A preprandial rise in plasma ghrelin levels suggests a role in meal initiation in humans. Diabetes 2001 50: 1714 9.
39. English PJ Ghatei MA Malik IA Bloom SR Wilding JP. Food fails to suppress ghrelin levels in obese humans. J Clin Endocrinol Metab 2002 87: 2984 7.
40. Beck B Musse N Stricker-Krongrad A. Ghrelin, macronutrient intake and dietary preferences in long-evans rats. Biochem Biophys Res Commun 2002 292: 1031 5.
41. Lee HM Wang G Englander EW Kojima M Greeley GH. Jr. Ghrelin, a new gastrointestinal endocrine peptide that stimulates insulin secretion: enteric distribution, ontogeny, influence of endocrine, and dietary manipulations. Endocrinology 2002 143: 185 90.
42. Broglio F Gottero C Prodam F Gauna C Muccioli G Papotti M et al. Non-acylated ghrelin counteracts the metabolic but not the neuroendocrine response to acylated ghrelin in humans. J Clin Endocrinol Metab 2004 89: 3062 5.
43. Marzullo P Verti B Savia G Walker GE Guzzaloni G Tagliaferri M et al. The relationship between active ghrelin levels and human obesity involves alterations in resting energy expenditure. J Clin Endocrinol Metab 2004 89: 936 9.